Delving into the Latest Updates on Saving Patients' Lives Medical BV with Synapse

Overview

A Confirmatory, Prospective, Open-label, Single-arm, Reader-blinded Multi-centre Phase 3 Study to Assess the Diagnostic Accuracy of Ferumoxtran-10-enhanced Magnetic Resonance Imaging (MRI) and Unenhanced MRI in Reference to Histopathology in Newly-diagnosed Prostate Cancer (PCA) Patients, Scheduled for Radical Prostatectomy (RP) With Extended Pelvic Lymph Node Dissection (ePLND).

This will be a confirmatory, prospective, open-label, single-arm, reader-blinded, multi-centre phase 3 study to assess the diagnostic accuracy and safety of Ferrotran®-enhanced MRI in comparison to unenhanced MRI in the detection of pelvic lymph node metastases in newly-diagnosed adult patients with prostate cancer and an intermediate to high risk for lymph node metastases, based on the D'Amico criteria.

Start Date27 May 2020

Sponsor / Collaborator

Saving Patients' Lives Medical BV

[+3]

100 Clinical Results associated with Saving Patients' Lives Medical BV

Login to view more data

0 Patents (Medical) associated with Saving Patients' Lives Medical BV

Login to view more data

100 Deals associated with Saving Patients' Lives Medical BV

Login to view more data

100 Translational Medicine associated with Saving Patients' Lives Medical BV

Login to view more data